aderma Latest News

The rights to Aderma® have been acquired by the UK subsidiary of Smith & Nephew

The Aderma® Dermal Pad range of products are the only pressure ulcer prevention devices to be made available on the Nottinghamshire Wound Care Formulary.

The Clinician Support Guide is the most advanced literature to date and includes information regarding how Aderma® actually works, when best to use it, how and where to use it, the clinical and cost benefits, ordering information and extra support.

At this year’s Wounds UK conference in Harrogate the new campaign was revealed and was extremely well received by all.

Aderma®: proven more efficient than controlled nursing treatment.

As a result of the recent acquisition of Drug Tariff status Aderma® has been propelled into community markets where growth and demand have never been so widespread.

The entire Aderma® range, consisting of heels, sacrum / ankle wrap, sheets and strips will be available on drug tariff from the 1st of August 2011.

The 30th Annual Tissue Viability Conference was this year held in Kettering, UK. The 2 day event began on the 5th of April and boasted an array of professionals with expertise in wound management and leading voices in tissue viability.

An article published within the Daily Mail last week titled “Why in the 21st Century are NHS patients dying in agony from bedsores?” highlights the harrowing experiences some patients endure whilst in the care of the NHS.

The relationship between quality and cost is one that for many years has been in conflict with one another.

In 2008 the Aderma® range was designed around a nurse and clinician led innovation. Today that commitment to their audience still remains as they prepare to launch 2 new products, extending the Aderma® range to 8 products.

British manufacturing is the 6th largest manufacturer in the world & works on a principle of identifying & fulfilling market niches through innovation whilst working alongside high valued supply chains, whish is significantly apparent than in the NHS

No matter how good something is it can always be improved by listening to someone who has more knowledge. In relation to Aderma® this could not be more true.

Twitter allows for many businesses and brands like FPD Medical Ltd and Aderma® to communicate to a mass audience and encourages interaction between business 2 business, business 2 consumer(s) and consumer 2 consumer.

Andrew Lansley, the Health Secretary, has proposed jobs throughout the NHS will have to be cut which has created concern among frontline nurses due to the repercussions this could have on themselves, patients safety and quality of care.

Plans to modernise the NHS are estimated to save £5 billion by 2015 and £1.7 billion every year after, however is this the most cost-effective, morale boosting and least disruptive way to ensue efficiency savings?

As a further 50 GP's sign up for David Cameron’s pilot scheme of the newly modernised NHS many businesses, including FPD Medical, develop growing concern over the impact it will have on their operation within the Healthcare market.

In September of 2010, a journalist reported on the number of Scottish patients dying in hospital due to pressure damage.

A recent clinical evaluation by the Tissue Viability Consultancy Services Ltd uncovers new ‘depths’ with regards to the use of Aderma® as a preventative pressure ulcer device.

2010 has been a monumental year for FPD Medical and Aderma® with many highlights throughout.

The evaluation at a large 78 bed nursing home involved training all staff in using best practices to deliver a cost effective solution to pressure ulcer reduction.

Recently the focus of the marketing department at FPD Medical has been the development of new communicational activities which will allow for new methods of interaction with acute trusts, with regards to the Aderma® brand.

The aim for the site was to create a central point where all Aderma® users could go and research solutions if they had any difficulties with the products.

Last week Aderma® was showcased at Wounds UK 2010 Harrogate with great success. The three day exhibition was established in conjunction with various other mass media communications for the sole purpose of providing affordable wound care education.

The awards ceremony was held on the 3rd November 2010 at the Hilton Hotel, Park Lane, London. Aderma® came first in the wound care and pressure ulcer prevention category and was awarded with the platinum position.

Focus Product Developments Ltd, an innovative medical device manufacturer based within the UK with over 75 years of combined experience, is planning taking a core section of its product portfolio and supplying it across Europe.

The Aderma sacrum pad helps maintain circulation and therefore helps reduce the risk of developing any category of pressure ulcer within the area of use.

In Early 2000 Focus Product Developments Ltd identified a niche in the medical device market. That niche was the opportunity to manufacture innovative product solutions, on a small scale.

The Aderma heel helps maintain circulation and therefore helps reduce the risk of developing any category of pressure ulcer within the area of use.

Aderma; used during Epidurals to help prevent pressure ulcers formulating

Aderma - 3,000+ NHS Supply Chain purchases since early 2009